home / stock / fms / fms news


FMS News and Press, Fresenius Medical Care AG From 02/20/19

Stock Information

Company Name: Fresenius Medical Care AG
Stock Symbol: FMS
Market: NYSE
Website: freseniusmedicalcare.com

Menu

FMS FMS Quote FMS Short FMS News FMS Articles FMS Message Board
Get FMS Alerts

News, Short Squeeze, Breakout and More Instantly...

FMS - Fresenius Medical Care reports Q4 results

Fresenius Medical Care (NYSE: FMS ): Q4 Non-GAAP EPS of €1.15; GAAP EPS of €1.38. More news on: Fresenius Medical Care AG & Co. KGAA, Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...

FMS - Fresenius, NxStage to divest bloodline tubing in FTC settlement

A settlement with the FTC calls for Fresenius Medical Care (NYSE: FMS ) and NxStage Medical (NASDAQ: NXTM ) to divest rights and assets tied to NxStage's bloodline tubing set business in order to consummate their acquisition deal. More news on: Fresenius Medical Care AG & Co. KGAA, N...

FMS - Notable earnings before Wednesday's open

ADI , AROC , BDC , BHC , CNDT , CVS , DAKT , ETR , FMS , GCI , GEL , GLDD , GRMN , GVA , HFC , HSIC , I , LAMR , NI , OC , OMI , QUAD , SAH , SO , WIX , WWW For Seeking Alpha's full earnings season calendar,  click here . More news on: Analog Devices Inc....

FMS - Dividend Portfolio Review: 22% Y/Y Growth In January

2019 started with a big rally. Following an initial slump, markets rose throughout the month as optimism regarding the outcome of China-U.S trade negotiations, a better-than-expected earnings season and a less hawkish Fed have provided lots of fuel. (Source: onvista.de - Dow Jones Last 3M )...

FMS - ChemoCentryx withdraws conditional approval application for avacopan in Europe

ChemoCentryx ( CCXI +0.3% ) has withdrawn its marketing application in Europe seeking conditional approval for avacopan (formerly CCX168) for the treatment of ANCA-associated vasculitis, an autoimmune disorder characterized by the inflammation and destruction of small vessels, a filing sub...

FMS - Road To Financial Independence: My December 100-Stock Portfolio Review

First of all, Happy New Year everybody! Similarly to 2017, 2018 closed with a bang, this time however the December rally from 2017 was replaced with the Christmas rout of 2018. The absolute low was reached on Christmas Eve but I had already spent too much during the year that I was lacking f...

FMS - Fresenius Medical Care (FMS) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

The following slide deck was published by Fresenius Medical Care AG & Co. KGAA in conjunction with this Read more ...

FMS - Portfolio Update: Stocks Getting Slammed As Dividends Shine Bright

My investment career is still very short (roughly 2.5 years) and as such the volatility we are now experiencing daily in the markets is certainly new to me. That said I have been actively watching how the stock markets behaved from 2007 - 2010 and although I am deeply regretting it not to have...

FMS - Week In Review: China Pharmas Announce Deals Worth $1.5 Billion

Deals and Financings WuXi AppTec (SHA: 603259), China's largest CRO/CMO, completed a $1 billion IPO on the Hong Kong markets, pricing the offering in the middle of the expected range. In May, WuXi became a public company by completing a $328 million IPO in Shanghai. Since the offering, the...

FMS - Fresenius down 10% premarket on softer guidance

Fresenius Medical Care (NYSE: FMS ) is down  10%  premarket on light volume following its statement that it does not believe its 2020 outlook is achievable considering its expectations for 2018 and 2019. More news on: Fresenius Medical Care AG & Co. KGAA, Healthcare stocks ...

Previous 10 Next 10